Health Care/Hospital

Visionary Has World-Class Biochip Technology Products

TORONTO, May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company has coopera...

2024-05-16 20:30 3161

EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress

SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been ...

2024-05-16 09:03 1796

LoRaWAN® Temperature and Humidity Sensors for Food Safety, Pharmaceutical and Beyond

XIAMEN, China, May 15, 2024 /PRNewswire/ -- In industries like pharmaceuticals, food, and logistics, maintaining the integrity of products throughout the supply chain is critical. Temperature and humidity are two key parameters that can significantly affect the quality and safety of goods, especi...

2024-05-15 23:05 1842

Momcozy Successfully Concluded Mother's Day Campaign "Momcozy Village" Supporting Motherhood

NEW YORK, May 15, 2024 /PRNewswire/ -- Reflecting on its recent Mother's Day campaign, Momcozy, a global one-stop mother and baby brand, reaffirms its commitment to supporting mothers through its "Momcozy Village

2024-05-15 22:00 2063

Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients

SUZHOU, China, May 15, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has approved the Investigat...

2024-05-15 20:00 1717

Novosis Putty Sets the Stage for U.S. Market Success with Promising Clinical Results

SEOUL, South Korea, May 14, 2024 /PRNewswire/ -- CGBio, a leading medical device company, announced a significant clinical results demonstrating a 100% interbody fusion success rate at 52 weeks for its innovative bone substitutes, "Novosis" and "Excelos Inject," which have been published in the '...

2024-05-14 20:00 1820

Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Annual Report on Form 10-K

NEW YORK, May 14, 2024 /PRNewswire/ -- Qomolangma Acquisition Corp. (Nasdaq: QOMO) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-K for the period endedDecember 31, 2...

2024-05-14 18:30 1729

Xinhua Silk Road: China's Tasly releases white paper, large model on TCM digital intelligence

BEIJING, May 14, 2024 /PRNewswire/ -- China's TCM product developer Tasly Pharmaceutical Group Co., Ltd. issued a white paper on digital intelligence of traditional Chinese medicine (TCM) and launched a related large model at an industrial conference onMay 9, 2024.

2024-05-14 17:07 1567

Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer

SHANGHAI, May 13, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targeting ADC (R&D code: 9MW2821) for triple-negative breast cancer. Based on 9MW2821's curren...

2024-05-13 22:00 1850

ObeEnd - Pioneering Drug-Free Weight Management Wristband

VANCOUVER, BC, May 13, 2024 /PRNewswire/ -- WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world's first weight management wristband backed by clinical evidence showcasing its efficacy in reducing dietary intake. Findings from this groundbreakin...

2024-05-13 21:00 1562

Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention

NEW TAIPEI CITY, May 11, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention onWednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in Com...

2024-05-11 15:14 3372

Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology

SHANGHAI, NANJING, China, and SAN JOSE, Calif., May 10, 2024 /PRNewswire/ -- On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal ofScience, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central...

2024-05-11 10:16 4354

Zepp Health Corporation Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price

MILPITAS, Calif., May 10, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") datedApril 30, 2024, notifying Zepp ...

2024-05-11 05:00 5827

Momcozy Celebrates Motherhood with "Momcozy Village" Event at Babylist Beverly Hills

NEW YORK, May 10, 2024 /PRNewswire/ -- On May 9th, Momcozy , a global leader in mother and baby care, hosted a heartwarming event at Babylist Beverly Hills as part of its "Momcozy Village

2024-05-10 22:00 1897

China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering

HANGZHOU, China, May 10, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ha...

2024-05-10 21:20 5696

Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)

SHENZHEN, China, May 10, 2024 /PRNewswire/ -- On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency (EMA) regulat...

2024-05-10 20:07 2373

Nuvilab Becomes B Corp Certified

SEOUL, South Korea, May 10, 2024 /PRNewswire/ -- Nuvilab, a leading provider of food vision AI, announced its recent achievement of becoming a certified B Corp. The designation, granted by the non-profit B Lab, highlights Nuvilab's commitment to a range of sustainable practices encompassing gover...

2024-05-10 19:59 2594

Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides

* FlexFactory platform for oligonucleotides, an integrated solution to boost efficiency and speed of pharmaceutical manufacturing to meet market demand SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing o...

2024-05-10 18:39 2260

WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval

CHENGDU, China, May 10, 2024 /PRNewswire/ -- WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA ...

2024-05-10 12:16 1914

SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer

SEOUL, South Korea, May 9, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101 ...

2024-05-10 12:00 1495
1 ... 42434445464748 ... 283